Thus, DBE-T appears to play a similar role through interaction with WDR5 to activate DUX4. They are currently testing the efficacy of WDR5 inhibitors in FSHD cell and animal models. This evidence concerns the gene WDR5 and facioscapulohumeral muscular dystrophy.